跳至主要内容
临床试验/NCT05489029
NCT05489029已完成不适用

Peculiarities of Pain in Patients With Gunshot Wounds Depending on the Localization of the Wound at the Stages of Treatment

Bogomolets National Medical University1 个研究点 分布在 1 个国家目标入组 1,555 人开始时间: 2022年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,555
试验地点
1
主要终点
visual analog scale

研究概览

简要总结

Chronic pain, in turn, is associated with a whole cohort of mutually aggravating factors - this can lead to the development of extremely serious long-term consequences. The features of pain in this category of patients have not been sufficiently studied. Taking into account continuity and consistency, clear and high-quality pain treatment is necessary at all stages of treatment.

详细描述

The peculiarities of pain in patients with gunshot wounds, depending on the localization of the wound at the stages of treatment, need to be studied, because the subjective feelings and emotional experiences experienced by patients during the wounding in combat conditions through the prism of psychological disorders have their own characteristics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • the presence of gunshot wounds

排除标准

  • no gunshot wounds

结局指标

主要结局

visual analog scale

时间窗: 12 months

from 0 to 10 points

pain diagnostic questionnaire

时间窗: 12 months

4 or more points (a neuropathic pain component is present)

The Hospital Anxiety and Depression Scale

时间窗: 12 months

0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity

Chaban Quality of Life Scale

时间窗: 12 months

up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high

Mississippi PTSD scale (military version)

时间窗: 12 months

the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vasyl' Horoshko

Chief researcher

Bogomolets National Medical University

研究点 (1)

Loading locations...

相似试验